[Skip to Content]

Upstate Active Clinical Trials

Study Title:

A RANDOMIZED PHASE III STUDY OF IBRUTINIB PLUS OBINUTUZUMAB VERSUS IBRUTINIB PLUS
VENETOCLAX AND OBINUTUZUMAB IN UNTREATED OLDER PATIENTS (>/= 70 YEARS OF AGE) WITH
CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)

Upstate Institutional Review Board (IRB) Number:

1417310

Study/Protocol ID:

A041702

Patient Age Group:

Adults

Principal Investigator:

David B Duggan, MD

What is involved if I participate?

  • Is transportation provided or reimbursed?
    No
  • Is parking provided or reimbursed?
    No

Where will the study take place?

SUNY Upstate Cancer Center
Upstate Cancer Center Hematology Oncology at Oswego
Upstate Cancer Center Hematology Oncology at Oneida

Who can I contact for more information?

Name: Corey Chase
Phone: 315-464-4187
Email: chasec@upstate.edu

Return to Previous Page || Search Again

Top